Literature DB >> 338634

Incidence of K1 antigen in Escherichia coli isolated from blood and cerebrospinal fluid of patients in the United Kingdom.

T Cheasty, R J Gross, B Rowe.   

Abstract

Altogether 411 cultures of Escherichia coli isolated from blood and 60 from cerebrospinal fluid (CSF) of patients in the United Kingdom were identified biochemically and serologically. They were tested for the presence of K1 antigen by an antiserum-agar method using horse meningococcus group B antiserum and by slide agglutination using E. coli 07.K1.H-antiserum. In total 71 cultures from blood (17%) and 29 from CSF (48%) gave positive results by both methods and were considered to possess the K1 antigen. Among the cultures from patients less than 3 years of age the K1 antigen was found significantly more often in those isolated from CSF (53%) than in those from blood (29%). The K1 antigen was found significantly more frequently in cultures isolated from the blood of patients less than 3 years old (29%) than in those from the blood of older patients (13%). Cultures which gave negative results in the slide agglutination test also gave negative results by the antiserum-agar method but positive results obtained by slide agglutination were not always confirmed using the antiserum-agar technique. Slide agglutination was considered to be valuable for the elimination of K1 negative cultures, but positive results required confirmation using the antiserum-agar method.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338634      PMCID: PMC476600          DOI: 10.1136/jcp.30.10.945

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

2.  Epidemiology of Escherichia coli K1 in healthy and diseased newborns.

Authors:  L D Sarff; G H McCracken; M S Schiffer; M P Glode; J B Robbins; I Orskov; F Orskov
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

  2 in total
  8 in total

Review 1.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

2.  Simple technique for detecting K1 antigen of Escherichia coli.

Authors:  D A Devine; A P Roberts; B Rowe
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

3.  Biochemical characteristics, phage patterns, and O1 factor analysis of Escherichia coli O1:K1:H7:F11 and O1:K1:H-:F9 strains isolated from patients with urinary tract infections.

Authors:  W Nimmich; G Zingler
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

4.  Increased frequency of ColV plasmids and mannose-resistant hemagglutinating activity in an Escherichia coli K1 population.

Authors:  M E Agüero; H Harrison; F C Cabello
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

5.  Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals.

Authors:  M Achtman; M Heuzenroeder; B Kusecek; H Ochman; D Caugant; R K Selander; V Väisanen-Rhen; T K Korhonen; S Stuart; F Orskov
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

6.  Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli.

Authors:  R J Gross; T Cheasty; B Rowe
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

7.  Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types.

Authors:  G Pluschke; A Mercer; B Kusećek; A Pohl; M Achtman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.

Authors:  F Orskov; I Orskov; A Sutton; R Schneerson; W Lin; W Egan; G E Hoff; J B Robbins
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.